UK Health Agency Overstated Positive Responses To Zocor Switch – Journal
This article was originally published in The Tan Sheet
Executive Summary
MHRA "inaccurately reported" the number of positive responses it received during a consultation period to switch Merck's Zocor Heart-Pro (simvastatin 10 mg) to nonprescription status in the UK, an article published in the Drug & Therapeutics Bulletin says
You may also be interested in...
UK Statin Comments Mistake Prompts Transparent Consultation Reports
The UK Medicines & Healthcare products Regulatory Agency will now publicly post responses for all public switch consultations as part of a new transparency effort
UK Statin Comments Mistake Prompts Transparent Consultation Reports
The UK Medicines & Healthcare products Regulatory Agency will now publicly post responses for all public switch consultations as part of a new transparency effort
UK Statin Comments Mistake Prompts Transparent Consultation Reports
The UK Medicines & Healthcare products Regulatory Agency will now publicly post responses for all public switch consultations as part of a new transparency effort